CRISPR/Cas-Based Epigenome Editing: Advances, Applications, and Clinical Utility

2021/05/07 by Jacob Goell, Jacob H. Goell, Isaac B. Hilton · 1 voice · 1 citation
Biochemistry, Genetics and Molecular Biology · #CRISPR and Genetic Engineering #Genetics, Aging, and Longevity in Model Organisms #Pluripotent Stem Cells Research

paper · doi:10.1016/j.tibtech.2020.10.012

openalex publication_date 2021/05/07 · crossref created 2021/05/07 · crossref issued 2021/07/01 · crossref published 2021/07/01 · crossref published-print 2021/07/01 · openalex created_date 2025/10/10 · crossref deposited 2026/04/29 · crossref indexed 2026/07/10 · openalex updated_date 2026/07/30

Citations

• A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
• Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants

Cited by

• CRISPR-epigenetic crosstalk: From bidirectional regulation to therapeutic potential

Discussions

• Check out this fantastic overview of epigenome editing across length scales. ➡️ Goell, J. H., & Hilton, I. B. (2021). CRISPR/CAS-Based Epigenome Editing: Advances, Applications, and Clinical Utility. [bsky, 4 points, 0 comments]